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Abstract
Background: This study analyzed PWAs in patients with high Framingham risk scores to determine whether PWA is
predictive of coronary artery disease (CAD) severity and percutaneous coronary intervention (PCI) treatment.
Methods: In total, 310 patients were screened due to suspected CAD; 78 were excluded due to PCI history (32),
atrial fibrillation (11), or acute myocardial infarction (35). The augmentation index (AIx) was analyzed immediately
before coronary angiography. PCI was performed in 73 (31.5 %) patients.
Results: The mean AIx, adjusted by heart rate (AIx@75) was different for each clinical diagnosis in the PCI group (stable
angina, 30.6 ± 7.7 %; silent ischemia, 30.2 ± 8.6 %; unstable angina, 38.5 ± 8.5 %; p = 0.026). The 10-year estimate of CVD
risk, based on the Framingham heart score, was 25.3 ± 6.5 % and the mean AIx@75 was 31.6 ± 8.5 % in the PCI group,
significantly higher than in the non-PCI group (18.8 ± 10.2 %, p < 0.001; 27.2 ± 9.0 %, p = 0.006, respectively). An inverse
correlation was observed between the minimal luminal area and AIx@75 (rho = −0.559, p = 0.010, n = 20). In ROC curve
analysis of multivariate logistic regression model, higher HDL, medication of hypertension, and higher body mass index
were associated with non-PCI and higher AIx@75 was associated with PCI (area under the curve, 0.764; 95 % CI: 0.701
to 0.819, z = 8.005; p <0.001).
Conclusions: The AIx@75 seemed to reflect the clinical severity of CAD and was associated with PCI in patients with a
high Framingham risk score.
Keywords: Atherosclerosis, Coronary artery disease, Risk factors, Waves
Background
In the Framingham Heart Study, pulse pressure (PP) was
reported to be a more important factor in cardiovascular
disease (CVD) than either systolic (SBP) or diastolic blood
pressure (DBP) [1]. PP, which is the difference between
the SBP and DBP, has been linked with an increased
prevalence of CVD and associated mortality [2–4]. An in-
creased PP results from an increase in SBP, due to in-
creased arterial stiffness and reflection pressure, and a
decreased DBP, due to reduced arterial elasticity. Together,
these factors are the elements of pulse wave analysis
(PWA). The central pulse wave is composed of an early
incident wave caused by left ventricular ejection and a
reflected wave from the periphery [5]. As arterial stiffness
increases, the velocity of the early incident wave and late
reflected wave increases. If the reflected wave arrives at
the central aorta early, the central aortic SBP rises. This
increased pressure is called augment pressure (AP), and
its percentage of the PP is called the augmentation index
(AIx). The AIx@75 is adjusted to the AIx based on the
heart rate [5].
Many studies have analyzed the ability of the AIx to
predict coronary artery disease (CAD) severity using
PWA [6–9]. In these studies, the definition of a CAD
was a minimal lumen diameter (MLD) stenosis >50 %,
as determined using coronary angiography (CAG).
Weber et al. [8] showed that patients with multi-vessel
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CAD had high AIx values. However, PWA has not been
implicated as a predictor of the need for percutaneous
coronary intervention (PCI) or the patient’s clinical diag-
nosis. Additionally, the Framingham risk score may
overestimate the CAD risk in the Chinese population
outside the United States [10]. However, the reason is
not clear.
The hypothesis of this study is as follows: the Framingham
risk score may overestimate the CAD risk in the Korean
population, because Koreans and Chinese live in the Far
East Asia. If not, PWA is possible to have a lower power
to predict the CAD in the patients with high Framingham
risk scores. Generally, CAG was performed in patients
with high Framingham risk scores and chest pain. There-
fore, this research is to find out whether PWA independ-
ently can predict the clinical severity of the CAD or the
need for percutaneous coronary intervention (PCI) in Ko-
rean patients with high Framingham risk scores.
Methods
Patient enrollment
This hospital-based observational study was approved by
the ethical committee of the institutional review board
of Jeju National University Hospital, and the need for
written informed consent was waived due to the non-
interventional nature of the study.
Between July and August 2012, 310 consecutive pa-
tients, from rural areas of Korea, were referred for elect-
ive CAG due to suspected CAD. Of these, 78 patients
were excluded due to a PCI history (32), atrial fibrilla-
tion (11), or acute myocardial infarction (35). Thus, 232
patients were ultimately enrolled in the study; none had
significant valvular heart diseases.
The CVD risk score was calculated using data from
the Framingham Heart Study [11]. The CVD risk points
included sex, age, hypertension, diabetes, smoking, total
cholesterol, high density- lipoprotein (HDL), and bra-
chial SBP. Hypertension and diabetes were defined as
being present if the patients were undergoing permanent
drug treatment. Current smoking status was defined as
the patient having smoked at least 1 cigarette within the
month prior to undergoing CAG.
Stable angina was defined as the presence of exertional
chest pain, a positive stress test, and a CAG-determined
MLD >50 % stenosis. Unstable angina was defined as
chest pain and electrocardiographic (ECG) ST-segment
depression or prominent T-wave inversion, and/or posi-
tive biomarkers of necrosis in the absence of ST-segment
elevation [12], and CAG-determined MLD >50 % stenosis.
Silent myocardial ischemia was defined as the absence of
chest pain and CAG-determined MLD >50 % stenosis.
After dividing the patients into the PCI and the non-PCI
groups, we analyzed their PWAs, degrees of coronary
stenosis, CAD severities, and CVD risk points.
Coronary angiography
A consent for CAG was written. All patients underwent
CAG while fasting, after having provided informed con-
sent. Normal saline was intravenously administered before
CAG to provide renal protection and to prepare for any
potential emergency. Quantitative coronary angiographic
analysis was performed using standard techniques and
automated edge-detection algorithms (ANCOR V2.0,
Siemens, Munich, Germany). Virtual histology intravascu-
lar ultrasound (VH-IVUS, Volcano Therapeutics, Rancho
Cordova, CA, USA) imaging was performed after intra-
coronary administration of nitroglycerin (0.2 mg) using a
motorized transducer pullback (0.5 mm/s). The IVUS
catheter was advanced 10 mm distal to the target lesion
and imaging was performed as the catheter was retracted
to the aorto-ostial junction. Off-line quantitative IVUS
analyses were performed with computed planimetry (Echo
Plaque 3.0, Indec Systems, Mountain View, CA, USA). If
diagnostic CAG failed to reveal significant stenosis (>50 %
diameter stenosis, based on quantitative angiographic ana-
lysis), increasing doses of intravenous ergonovine (100
and 200 μg) were administered every 2 min until coronary
artery spasms were provoked; a standard, 12-lead electro-
cardiogram was monitored. Variant angina was defined as
chest pain and electrocardiographic evidence of myocar-
dial ischemia and/or severe transient coronary stenosis.
The PCI indications were ≥75 % stenosis, based on
quantitative coronary angiographic analysis, or a minimal
lumen area (MLA) <4.0 mm2, determined using IVUS.
PWA
All antihypertensive medicines were withdrawn, and the
patients fasted for at least 12 h prior to PWA. Brachial BP
measurements and PWA were performed in the supine
position after 10 min of rest, immediately prior to CAG.
Brachial BP was measured before PWA by digital sphygmo-
manometer (Omron® M6, Omron Corporation, Kyoto,
Japan). We analyzed the waveforms of each patient’s central
aortic pressure using SphygmoCor® (AtCor, Sydney, NSW,
Australia) after applanation of the left radial artery and re-
cording the central aortic pressure estimate. PWA using
SphygmoCor® provided central systolic, diastolic, mean, and
central pulse pressures, as well as AP, AIx, and AIx@75.
Statistical analyses
Statistical analyses were performed using SPSS 17.0 soft-
ware (SPSS, Chicago, IL, USA). Data are presented as
means ± standard deviations for continuous variables or as
frequencies for categorical variables. Comparisons of cat-
egorical variables were performed using chi-square tests,
and between-group (clinical diagnoses, the severity of CAD)
comparisons were performed using one-way analysis of
variance, followed by a post hoc analysis and Bonferroni
correction. Spearman and Pearson correlation analysis were
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used to evaluate the trends between the AIx@75 and other
parameters. Analysis of covariance was also run to compare
the AIx@75 s between the PCI and non-PCI groups (adjust-
ing for echocardiographically determined ejection fraction)
and among clinical diagnoses (adjusting for age, HDL chol-
esterol level, and ejection fraction). A multiple linear regres-
sion analysis was performed to examine the predictors of
AIx@75. A multivariate logistic regression analysis was per-
formed to identify the variables independently related with
the predictors of AIx@75 and to determine the probability
of PCI. Receiver operating characteristics (ROC) curve ana-
lysis was used to identify the probability of AIx@75 and the
risk factors, using logistic regression analysis with a forward
(conditional) selection, best predicting PCI. The adequacy
of the multivariable logistic regression analysis was assessed
using coefficient of determination (R2) and area under curve
(AUC) determinations; p ≤ 0.05 was considered significant.
Results
Baseline characteristics
In total, 73 patients (31.5 %) undergoing PCIs partici-
pated in this study. 216 patients had a mean CVD score,
according to the Framingham heart study, of 16.1 ± 5.3.
The 10-year estimate of their CVD risk was 20.9 ± 9.6 %.
Because there were no HDL data of 16 patients, the
CVD score and the 10-year estimate of CVD risk could
not be calculated. In the PCI group, the clinical diagno-
ses included stable angina (n = 47), silent ischemia (n =
13), and unstable angina (n = 13). The CAD severity was
expressed as 1-vessel disease (VD), 2-VD, and 3-VD.
Among the patients undergoing PCI, 26 had 1-VD, 19
had 2-VD, and 28 had 3-VD. In the PCI group, the mean
age was 64.8 ± 10.3 years, and the mean Framingham
Heart Study CVD score was 18.6 ± 4.0 (n = 70). These
values were significantly higher in the PCI group than in
the non-PCI group (age, 59.6 ± 13.1 years; Framingham
score, 14.9 ± 5.4, n = 146). Hypertension (72.6 % vs.
49.1 %) and hyperlipidemia (46.6 % vs. 28.9 %) were
more frequently noted in the PCI group than in the
non-PCI group. The 10-year CVD risk estimate was also
higher in the PCI group (25.3 ± 6.5 %, n = 70) than in the
non-PCI group (18.8 ± 10.2 %, n = 146; Table 1).
PWA
The AP (20.3 ± 9.5 mmHg), AIx (36.5 ± 9.3 %), and
AIx@75 (31.6 ± 8.5 %) were higher in the PCI group
than in the non-PCI group (16.9 ± 8.8 mmHg, 32.5 ±
10.0 %, 27.2 ± 9.0 %, respectively; Table 1). The AIx@75,
adjusted for the left ventricular ejection fraction, was
also significantly different between the PCI and the non-
PCI groups (n = 111, p = 0.006). However, there were no
significant differences between the PCI and the non-PCI
groups with respect to brachial or central PP. The
AIx@75 was significantly different for each clinical
diagnosis in the PCI group (stable angina, 30.6 ± 7.7 %;
silent ischemia, 30.2 ± 8.6 %; unstable angina, 38.5 ±
8.5 %; p = 0.035, adjusted for left ventricular ejection
fraction, age, sex). The AIx@75 was consistently differ-
ent among the disease severity classifications within the
PCI group (1-VD, 29.8 ± 7.8 %; 2-VD, 30.1 ± 8.0 %; 3-VD,
34.3 ± 8.5 %; p = 0.109), but the differences were statisti-
cally insignificant (Fig. 1).
Statistically significant correlations between the risk
factors based on the Framingham Heart Study and
AIx@75 were observed in the non-PCI group (age, ρ =
0.383, p < 0.001; brachial PP, ρ = 0.223, p = 0.005; brachial
SBP, ρ = 0.241, p = 0.002; height, ρ = −0.359, p < 0.001
and body mass index (BMI), ρ = −0.178, p = 0.025). Sta-
tistically significant correlations between the risk factors
from the Framingham Heart Study and AIx@75 were
observed in the PCI group (age, ρ = 0.473, p < 0.001; bra-
chial PP, ρ = 0.378, p < 0.001; brachial SBP, ρ = 0.261, p =
0.026 and height, ρ = −0.514, p < 0.001). The AIx@75
Table 1 Baseline characteristics and pulse wave analysis
PCI group Non-PCI group p
n = 73 (%) n = 159 (%)
Male 50 (68.5) 97 (61.0) 0.306
Age (years) 64.8 ± 10.3 59.6 ± 13.1 0.001
Height (cm) 163.8 ± 7.7 163.0 ± 8.5 0.486
Body weight (Kg) 66.9 ± 11.4 68.2 ± 11.4 0.442
Body mass index (kg/m2) 24.8 ± 3.5 25.6 ± 3.2 0.085
Brachial systolic pressure (mmHg) 148.9 ± 22.4 144.1 ± 22.6 0.135
Brachial diastolic pressure (mmHg) 87.0 ± 11.0 85.1 ± 10.5 0.203
Brachial pulse pressure (mmHg) 61.8 ± 17.6 58.7 ± 17.6 0.216
CVD risk points 18.6 ± 4.0 14.9 ± 5.4 <0.001*
10-year estimate of CVD risk (%) 25.3 ± 6.5 18.8 ± 10.2 <0.001*
Diabetes 20 (27.4) 33 (20.8) 0.312
Hypertension 53 (72.6) 78 (49.1) 0.001
Hyperlipidemia 34 (46.6) 46 (28.9) 0.011
Total cholesterol (mg/dL) 181.1 ± 45.6 185.9 ± 54.0 0.513
HDL cholesterol (mg/dL) 41.0 ± 11.2 46.0 ± 12.3 0.002*
Smoking 24 (32.9) 40 (25.2) 0.268
Left ventricular ejection fraction
(n = 111)
59.0 ± 14.5 65.3 ± 10.1 0.036
Central pulse pressure (mmHg) 53.4 ± 17.1 49.4 ± 18.0 0.110
Augmented pressure (mmHg) 20.3 ± 9.5 16.9 ± 8.8 0.009
Augmentation index (%) 36.5 ± 9.3 32.5 ± 10.0 0.004
Augmentation index @75 (%) 31.6 ± 8.5 27.2 ± 9.0 0.006**
CVD cardiovascular disease, HDL high-density lipoprotein, PCI percutaneous
coronary intervention, Data are expressed as means ± standard deviation or
numbers (percentage); chi-square test or Wilcoxon two-sample test
(or Mann–Whitney U test)
*p value for comparison between the PCI (n = 70) and non-PCI (n = 146); p < 0.05
considered significant
**ANCOVA test: adjusting for ejection fraction (n = 111)
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was associated with age, sex, and brachial DBP, as deter-
mined using multiple linear regression analysis, in the
non-PCI group. The AIx@75 was associated with age,
sex, and smoking status using multiple linear regression
analysis in the PCI group (Table 2).
Analysis of correlation between VH-IVUS and AIx@75
VH-IVUS was performed in 20 patients, revealing a
mean MLA of 4.0 ± 2.1 mm2 and a mean dense calcium
volume value of 10.7 ± 15.5 mm3. A significant, inverse
correlation between the MLA and AIx@75 was observed
(rho = −0.559, p = 0.010). The dense calcium volume and
AIx@75 did not seem to be correlated (Table 3, Fig. 2).
Cardiovascular risk points and AIx@75
A statistically significant correlation between the
Framingham risk score and the AIx@75 was observed
(ρ = 0.358, p < 0.001, n = 216). In a multivariate logistic re-
gression analysis, the higher HDL (Odds ratio [OR], 0.963;
95 % confidence interval [CI], 0.937–0.989; p = 0.006),
medication of hypertension (OR, 0.404; 95 % CI, 0.204-
0.800; p = 0.009), and higher of BMI (OR, 0.891; 95 % CI,
0.805-0.985; p = 0.025) were associated with non-PCI.
Higher of AIx@75 (OR, 1.048; 95 % CI, 1.009–1.088; p =
0.015) was independently associated with PCI (Table 4).
The probability of PCI was calculated using a multivariate
logistic regression analysis. The statistics related to the
Fig. 1 Augmentation index @ 75 and the severity of coronary artery disease. *ANCOVA test, adjusting for age, sex, ejection fraction. PCI,
percutaneous coronary intervention
Table 2 Correlation of augmentation index@75 with risk factors
Non-PCI group PCI group
Multiple regression Multiple regression
ρ p r2 p ρ p r2 p
0.396 <0.001 0.488 <0.001
β p β p
Age 0.383 <0.001 0.250 <0.001 0.473 <0.001 0.282 0.014
Male −4.333 0.029 −5.691 0.043
BPP (mmHg) 0.223 0.005 0.156 0.346 0.378 <0.001 0.071 0.243
BSBP (mmHg) 0.241 0.002 −0.145 0.323 0.261 0.026 0.106 0.263
BDBP (mmHg) 0.149 0.061 0.387 0.009 −0.079 0.507 0.006 0.796
Total cholesterol (mg/dL) −0.026 0.748 0.005 0.718 0.067 0.578 0.039 0.648
HDL cholesterol (mg/dL) 0.150 0.071 0.03 0.608 −0.077 0.528 −0.310 0.057
Height (m) −0.359 <0.001 −0.17 0.141 −0.514 <0.001 −0.193 0.470
BMI (kg/m2) −0.178 0.025 −0.429 0.056 −0.081 0.497 −0.938 0.692
Hypertension 2.61 0.089 3.538 0.097
Diabetes −3.161 0.067 0.043 0.983
Smoking −2.294 0.146 6.142 0.007
PCI percutaneous coronary intervention, BPP brachial pulse pressure, BSBP brachial systolic blood pressure, BDPB brachial diastolic blood pressure, HDL high-density
lipoprotein, PCI percutaneous coronary intervention, BMI body mass index
p < 0.05 considered significant; ρ, Pearson correlation analysis
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calculated probability of PCI were sensitivity, 31.4 %; spe-
cificity, 87.0 %; positive predictive value, 53.7 %; negative
predictive value, 72.6 %; OR (the probability that the PCI
group is related to the risk factors by the multivariate
logistic regression analysis, compared to the non-PCI
group), 3.06; relative risk (the probability that the risk fac-
tors by the multivariate logistic regression analysis are re-
lated to the PCI group compared to non-risk factors by
the multivariate logistic regression analysis) 1.96. In ROC
curve analysis of multivariate logistic regression model,
higher HDL, medication of hypertension, and higher body
mass index were associated with non-PCI and higher
AIx@75 was associated with PCI (area under the curve,
0.764; 95 % CI: 0.701 to 0.819, z = 8.005; p <0.001).
Discussion
This study analyzed (1) the relationship between AIx@75
and CAD clinical severity, (2) the relationship between
AIx@75 and IVUS findings, and (3) the association of a
high CVD risk profile, based on the Framingham risk
score, with the AIx@75.
CAD and PWA
The AIx@75 was found to vary depending on the pa-
tient’s clinical diagnosis. Patients with unstable angina
were found to have especially high AIx@75 values. A
significant inverse correlation was observed, in this
study, between the MLA, determined using IVUS, and
the AIx@75. According to the analysis of the relation-
ship between pulse wave velocity (PWV) and VH-IVUS
[13], patients with higher PWVs had smaller MLAs. The
AIx@75 values tended to differ depending on disease se-
verity (1-, 2-, and 3- VD) and to correlate with the dense
calcium volume in the arterial plaque, but the relation-
ship was not statistically significant. This suggests that
the dense calcium volume may not be associated with
the clinical disease severity. The relationship between
cardiac ischemia and PWA can be explained as an
increased AIx, resulting from an increased central SBP
(increasing myocardial oxygen demand) and a decreased
central DBP (disturbed coronary blood flow), contri-
buting to an imbalance between oxygen demand and
supply; these factors occur due to ischemia [14]. Unfor-
tunately, this theory does not explain the relationship
between high AIx and unstable angina. According to
recent studies, patients with high AIx values demon-
strate poor outcomes [15]. Unstable angina, a manifest-
ation of acute coronary syndrome, can be dangerous and
may recur without appropriate intervention, supporting
our findings of patients with unstable angina having
high AIx.
PWA and Framingham risk score
Risk score systems were developed to predict CVD in pa-
tients with atherosclerosis. Therefore, higher risk scores
correlate with more frequent atherosclerotic events. Thus,
a correlation is expected between these risk score systems
and the AIx@75, as proven in many studies [6, 8, 16, 17].
In this study, we confirmed the correlation between the
Framingham risk score and the AIx@75. However, the
Framingham risk score has been suggested to possibly
overestimate the risk in the Chinese populations [10].
Thus, the risk estimation may be affected by other races
and environments, as well. The study population in the
present study involved Asians and rural inhabitants. The
patients had high risk scores and chest pain, leading to
their undergoing CAG. Hence, this study attempted to
determine whether PWA predicted the need for PCI in
Koreans living in rural areas and having high-risk scores.
Table 3 Analysis of the correlation between the virtual
histology intravascular ultrasound parameters and the
augmentation index @ 75 at the lesion site
Augmentation index @ 75
rho* p
EEM area (mm2) −0.288 0.219
Minimal luminal area (mm2) −0.559 0.010
Plaque and medial area (mm2) −0.156 0.511
Fibrous volume (mm3) 0.371 0.107
Fibro-fatty volume (mm3) 0.141 0.553
Necrotic-core volume (mm3) 0.283 0.226
Dense calcium volume (mm3) 0.437 0.054
Fibrous volume composition (%) −0.046 0.847
Fibro-fatty volume composition (%) −0.163 0.493
Necrotic-core volume composition (%) 0.107 0.655
Dense calcium volume composition (%) 0.418 0.067
EEM, external elastic membrane
p < 0.05 considered significant; *rho, Spearman correlation analysis
Fig. 2 Relationship between minimal lumen area (determined using
intravascular ultrasound) and the augmentation index @ 75
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In this study, the AIx@75 was associated with age, sex,
and smoking history for patients undergoing PCI; in the
non-PCI group, the AIx@75 was associated with age,
sex, and brachial DBP. Age has been a known determin-
ant of the AIx@75 [18]. In a previous study, PWA was
suggested to be a more sensitive predictor of risk in
younger patients [8]. But, a different study suggested
that the predictive power of PWA might not be limited
to younger patients [15]. The smoking history was not
associated with AIx@75 in young general population
[19]. In the present study, the enrolled patients were eld-
erly and had high risk factors, but those did not limit
the predictive value of AIx@75.
The higher HDL, medication of hypertension, and higher
of BMI were associated with non-PCI and higher of
AIx@75 was associated with PCI in the study population,
based on multivariable (Framingham risk factors; age, sex,
brachial BP, BMI, medications for hypertension and
diabetes, smoking, total cholesterol level, and HDL-
cholesterol level) analysis. This is unlikely due to the low
predictiveness of other risk factors, but due to the
high-risk scores and normal BMI in the study patients.
Interestingly, the probability of PCI, calculated using a
multivariate logistic regression model (AIx@75, age, BMI
and HDL), had a high OR and relative risk. Additionally,
the patients with unstable angina had the highest AIx@75
values after each clinical diagnosis, adjusted for suspicious
confounding factors. Therefore, AIx@75 was associated
with PCI and clinical severity in Korean patients living in
rural areas and having high Framingham risk scores.
PWA by an invasive study presents technical problems
because the selection of inflection points is not easy. In this
study, SphygmoCor® was used for PWA after applanation
of the left radial artery. The device finds an inflection
point mathematically and mechanically, following an ana-
lysis of the relationship between the second zero crossing
of the fourth derivative and the peak flow time, using the
formula: y = 0.91 + 1.31x; R = 0.75, where x is the time to
the second zero crosses the fourth derivative, and y is the
peak flow time [20]. Therefore, the AIx and related pa-
rameters can be measured easily, efficiently, and safely
using this method.
PWA is well known to be related to CAD and the
Framingham risk factors. PWAs, especially the AIx@75
values, also vary depending on the CAD clinical severity.
The AIx@75, determined using PWA, was associated
with PCI in patients with high Framingham risk scores.
Limitations
This study has some limitations. First, this was a hospital-
based observational study and the AIx@75 may have been
affected by confounding factors. Additionally, echocardiog-
raphy and HDL were not performed in all patients. How-
ever, verification by multivariate logistic regression analysis
and analysis of covariance minimized this limitation. The
second limitation of our study is the relatively small num-
ber of patients. The third, history of smoking, hypertension,
obesity and diabetes was poor assessment. However, this
study was based on risk factors from Framingham study.
Therefore, the study could not consider all of the risk fac-
tors in detail. The fourth, according to a recent study, sig-
nificant coronary stenosis tended to be determined by
fractional flow reserve rather than the MLA by IVUS [21].
However, this study did not include the fractional flow re-
serve. Hence, a well-designed larger cohort study is needed
to confirm these results and expand upon this limitation.
Table 4 Logistic regression of the Framingham risk factors and the augmentation index @ 75 for the prediction of percutaneous
coronary intervention
Variable B p Odds ratio 95 % CI B p Odds ratio 95 % CI
Age 0.038 0.052 1.039 1.000-1.080
Male −0.345 0.420 0.708 0.306-1.638
BSBP (mmHg) −0.034 0.846 0.967 0.688-1.359
BDBP (mmHg) 0.071 0.685 1.073 0.763-1.508
BPP (mmHg) 0.024 0.892 1.024 0.727-1.442
BMI (kg/m2) −0.132 0.022 0.876 0.783-0.981 −0.116 0.025* 0.891 0.805-0.985
Total cholesterol (mg/dL) 0.004 0.27 1.004 0.997-1.010
HDL (mg/dL) −0.043 0.006 0.958 0.929-0.988 −0.038 0.006* 0.963 0.937-0.989
Hypertension −0.753 0.055 0.471 0.218-1.016 −0.905 0.009* 0.404 0.204-0.800
Diabetes −0.137 0.725 0.872 0.407-1.869
Smoking 0.358 0.390 1.431 0.632-3.237
Augmentation index @75 (%) 0.040 0.092 1.041 0.994-1.090 0.047 0.015* 1.048 1.009-1.088
BSBP brachial systolic blood pressure, BDPB brachial diastolic blood pressure, BPP brachial pulse pressure, BMI body mass index, HDL high-density lipoprotein,
CI confidence interval
p < 0.05 considered significant
*Variable by logistic regression analysis with a forward (conditional) selection
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Conclusion
The AIx@75 seems to reflect the clinical severity
of CAD in the studied patient population. The AIx@75,
determined using PWA, was associated with PCI in
patients with high Framingham risk scores.
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